ブリナツモマブ薬の世界市場2020-2026:事前入力済み、未入力済み

QYResearchが発行した調査報告書(QYR20AP00356)
◆英語タイトル:Global Blinatumomab Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP00356
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥563,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥845,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,127,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、ブリナツモマブ薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ブリナツモマブ薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(事前入力済み、未入力済み)、用途別市場規模(病院、薬局)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ブリナツモマブ薬の種類別市場2015-2026:事前入力済み、未入力済み
・ブリナツモマブ薬の用途別市場2015-2026:病院、薬局
・ブリナツモマブ薬の北米市場分析
・ブリナツモマブ薬のアジア市場分析
・ブリナツモマブ薬の中南米市場分析
・ブリナツモマブ薬の中東・アフリカ市場分析
・関連企業情報:Amgen
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.In 2019, the global Blinatumomab Drugs market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Blinatumomab Drugs.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Blinatumomab Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Blinatumomab Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Blinatumomab Drugs market. Readers of the report can become informed about current and future trends of the global Blinatumomab Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Blinatumomab Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Blinatumomab Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Blinatumomab Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Blinatumomab Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Blinatumomab Drugs market is segmented into
Prefilled
Non-prefilled

Market Segment by Application, the Blinatumomab Drugs market is segmented into
Hospital
Pharmacy

This report includes the following manufacturers; we can also add the other companies as you want.
Amgen

The study objectives are:
To analyze and research the global Blinatumomab Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Blinatumomab Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Blinatumomab Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Blinatumomab Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Blinatumomab Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Prefilled
1.3.3 Non-prefilled
1.4 Market Segment by Application
1.4.1 Global Blinatumomab Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Blinatumomab Drugs Revenue (2015-2026)
2.1.1 Global Blinatumomab Drugs Revenue (2015-2026)
2.1.2 Global Blinatumomab Drugs Sales (2015-2026)
2.2 Blinatumomab Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Blinatumomab Drugs Sales by Regions (2015-2020)
2.2.2 Global Blinatumomab Drugs Revenue by Regions (2015-2020)
2.3 Global Top Blinatumomab Drugs Regions (Countries) Ranking by Market Size
2.4 Blinatumomab Drugs Industry Trends
2.4.1 Blinatumomab Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Blinatumomab Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Blinatumomab Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Blinatumomab Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Blinatumomab Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Blinatumomab Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Blinatumomab Drugs Sales in 2019
3.2 Global Top Manufacturers Blinatumomab Drugs by Revenue
3.2.1 Global Blinatumomab Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Blinatumomab Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Blinatumomab Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blinatumomab Drugs as of 2019)
3.4 Global Blinatumomab Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Blinatumomab Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Blinatumomab Drugs Market
3.7 Key Manufacturers Blinatumomab Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Blinatumomab Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Blinatumomab Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Blinatumomab Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Blinatumomab Drugs Price by Type (2015-2020)
4.1 Global Blinatumomab Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Blinatumomab Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Blinatumomab Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Blinatumomab Drugs Price Forecast by Type (2021-2026)

5 Global Blinatumomab Drugs Market Size by Application
5.1 Global Blinatumomab Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Blinatumomab Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Blinatumomab Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Blinatumomab Drugs Price by Application (2015-2020)
5.2 Global Blinatumomab Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Blinatumomab Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Blinatumomab Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Blinatumomab Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Blinatumomab Drugs Breakdown Data by Company
6.2 North America Blinatumomab Drugs Breakdown Data by Type
6.3 North America Blinatumomab Drugs Breakdown Data by Application
6.4 North America Blinatumomab Drugs Breakdown Data by Countries
6.4.1 North America Blinatumomab Drugs Sales by Countries
6.4.2 North America Blinatumomab Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Blinatumomab Drugs Breakdown Data by Company
7.2 Europe Blinatumomab Drugs Breakdown Data by Type
7.3 Europe Blinatumomab Drugs Breakdown Data by Application
7.4 Europe Blinatumomab Drugs Breakdown Data by Countries
7.4.1 Europe Blinatumomab Drugs Sales by Countries
7.4.2 Europe Blinatumomab Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Blinatumomab Drugs Breakdown Data by Company
8.2 Asia Pacific Blinatumomab Drugs Breakdown Data by Type
8.3 Asia Pacific Blinatumomab Drugs Breakdown Data by Application
8.4 Asia Pacific Blinatumomab Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Blinatumomab Drugs Sales by Regions
8.4.2 Asia Pacific Blinatumomab Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Blinatumomab Drugs Breakdown Data by Company
9.2 Latin America Blinatumomab Drugs Breakdown Data by Type
9.3 Latin America Blinatumomab Drugs Breakdown Data by Application
9.4 Latin America Blinatumomab Drugs Breakdown Data by Countries
9.4.1 Latin America Blinatumomab Drugs Sales by Countries
9.4.2 Latin America Blinatumomab Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Blinatumomab Drugs Breakdown Data by Type
10.2 Middle East and Africa Blinatumomab Drugs Breakdown Data by Application
10.3 Middle East and Africa Blinatumomab Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Blinatumomab Drugs Sales by Countries
10.3.2 Middle East and Africa Blinatumomab Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Amgen Blinatumomab Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Amgen Blinatumomab Drugs Products and Services
11.1.5 Amgen SWOT Analysis
11.1.6 Amgen Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Blinatumomab Drugs Sales Channels
12.2.2 Blinatumomab Drugs Distributors
12.3 Blinatumomab Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Blinatumomab Drugs Sales Forecast (2021-2026)
13.1.1 Global Blinatumomab Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Blinatumomab Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Blinatumomab Drugs Sales Forecast (2021-2026)
13.2.2 North America Blinatumomab Drugs Revenue Forecast (2021-2026)
13.2.3 North America Blinatumomab Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Blinatumomab Drugs Sales Forecast (2021-2026)
13.3.2 Europe Blinatumomab Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Blinatumomab Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Blinatumomab Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Blinatumomab Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Blinatumomab Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Blinatumomab Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Blinatumomab Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Blinatumomab Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Blinatumomab Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Blinatumomab Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Blinatumomab Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Blinatumomab Drugs Key Market Segments
Table 2. Ranking of Global Top Blinatumomab Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Blinatumomab Drugs Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Prefilled
Table 5. Major Manufacturers of Non-prefilled
Table 6. Global Blinatumomab Drugs Market Share by Application 2019-2025 (K Units)
Table 7. Global Blinatumomab Drugs Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Blinatumomab Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Blinatumomab Drugs Sales Market Share by Regions 2015-2020
Table 10. Global Blinatumomab Drugs Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Blinatumomab Drugs Revenue Market Share by Regions 2015-2020
Table 12. Top Blinatumomab Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Blinatumomab Drugs Key Drivers: Impact Analysis (2021-2026)
Table 15. Blinatumomab Drugs Key Challenges
Table 16. Main Points Interviewed from Key Blinatumomab Drugs Players: Views for Future
Table 17. Global Blinatumomab Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Blinatumomab Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Blinatumomab Drugs Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Blinatumomab Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Global Blinatumomab Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blinatumomab Drugs as of 2019)
Table 23. Key Manufacturers Blinatumomab Drugs Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 24. Key Manufacturers Blinatumomab Drugs Plants/Factories Distribution
Table 25. Key Manufacturers Blinatumomab Drugs Area Served
Table 26. Date of Key Manufacturers Enter into Blinatumomab Drugs Market
Table 27. Key Manufacturers Blinatumomab Drugs Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Prefilled Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 30. Global Non-prefilled Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Blinatumomab Drugs Sales (K Units) by Type (2015-2020)
Table 32. Global Blinatumomab Drugs Sales Share by Type (2015-2020)
Table 33. Global Blinatumomab Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Blinatumomab Drugs Price (K Units) by Type (2015-2020)
Table 35. Global Blinatumomab Drugs Sales (K Units) by Type (2021-2026)
Table 36. Global Blinatumomab Drugs Sales Share by Type (2021-2026)
Table 37. Global Blinatumomab Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Blinatumomab Drugs Revenue Share by Type (2021-2026)
Table 39. Global Blinatumomab Drugs Price (K Units) by Type (2021-2026)
Table 40. Global Blinatumomab Drugs Sales (K Units) by Application (2015-2020)
Table 41. Global Blinatumomab Drugs Sales Share by Application (2015-2020)
Table 42. Global Blinatumomab Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Blinatumomab Drugs Price by Application 2015-2020 (USD/Unit)
Table 44. Global Blinatumomab Drugs Sales by Application (2015-2020) (K Units)
Table 45. Global Blinatumomab Drugs Sales Share by Application (2015-2020)
Table 46. Global Blinatumomab Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Blinatumomab Drugs Revenue Share by Application (2021-2026)
Table 48. Global Blinatumomab Drugs Price (K Units) by Application (2021-2026)
Table 49. North America Blinatumomab Drugs Sales by Company (2015-2020) (K Units)
Table 50. North America Blinatumomab Drugs Sales Market Share by Company (2015-2020)
Table 51. North America Blinatumomab Drugs Sales by Type (2015-2020) (K Units)
Table 52. North America Blinatumomab Drugs Sales Market Share by Type (2015-2020)
Table 53. North America Blinatumomab Drugs Sales by Application (2015-2020) (K Units)
Table 54. North America Blinatumomab Drugs Sales Market Share by Application (2015-2020)
Table 55. North America Blinatumomab Drugs Sales by Countries (2015-2020) (K Units)
Table 56. North America Blinatumomab Drugs Sales Market Share by Countries (2015-2020)
Table 57. North America Blinatumomab Drugs Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Blinatumomab Drugs Revenue Market Share by Countries (2015-2020)
Table 59. Europe Blinatumomab Drugs Sales by Company (2015-2020) (K Units)
Table 60. Europe Blinatumomab Drugs Sales Market Share by Company (2015-2020)
Table 61. Europe Blinatumomab Drugs Sales by Type (2015-2020) (K Units)
Table 62. Europe Blinatumomab Drugs Sales Market Share by Type (2015-2020)
Table 63. Europe Blinatumomab Drugs Sales by Application (2015-2020) (K Units)
Table 64. Europe Blinatumomab Drugs Sales Market Share by Application (2015-2020)
Table 65. Europe Blinatumomab Drugs Sales by Countries (2015-2020) (K Units)
Table 66. Europe Blinatumomab Drugs Sales Market Share by Countries (2015-2020)
Table 67. Europe Blinatumomab Drugs Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Blinatumomab Drugs Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Blinatumomab Drugs Sales by Regions (2015-2020) (K Units)
Table 70. Asia Pacific Blinatumomab Drugs Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Blinatumomab Drugs Sales by Type (2015-2020) (K Units)
Table 72. Asia Pacific Blinatumomab Drugs Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Blinatumomab Drugs Sales by Application (2015-2020) (K Units)
Table 74. Asia Pacific Blinatumomab Drugs Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Blinatumomab Drugs Sales by Countries (2015-2020) (K Units)
Table 76. Asia Pacific Blinatumomab Drugs Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Blinatumomab Drugs Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Blinatumomab Drugs Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Blinatumomab Drugs Sales by Company (2015-2020) (K Units)
Table 80. Latin America Blinatumomab Drugs Sales Market Share by Company (2015-2020)
Table 81. Latin America Blinatumomab Drugs Sales by Type (2015-2020) (K Units)
Table 82. Latin America Blinatumomab Drugs Sales Market Share by Type (2015-2020)
Table 83. Latin America Blinatumomab Drugs Sales by Application (2015-2020) (K Units)
Table 84. Latin America Blinatumomab Drugs Sales Market Share by Application (2015-2020)
Table 85. Latin America Blinatumomab Drugs Sales by Countries (2015-2020) (K Units)
Table 86. Latin America Blinatumomab Drugs Sales Market Share by Countries (2015-2020)
Table 87. Latin America Blinatumomab Drugs Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Blinatumomab Drugs Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Blinatumomab Drugs Sales by Type (2015-2020) (K Units)
Table 90. Middle East and Africa Blinatumomab Drugs Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Blinatumomab Drugs Sales by Application (2015-2020) (K Units)
Table 92. Middle East and Africa Blinatumomab Drugs Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Blinatumomab Drugs Sales by Countries (2015-2020) (K Units)
Table 94. Middle East and Africa Blinatumomab Drugs Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Blinatumomab Drugs Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Blinatumomab Drugs Revenue Market Share by Countries (2015-2020)
Table 97. Amgen Company Details
Table 98. Amgen Description and Business Overview
Table 99. Amgen Blinatumomab Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Amgen Blinatumomab Drugs Sales Growth Rate (2015-2020)
Table 101. Amgen Blinatumomab Drugs Sales Market Share in Global Market
Table 102. Amgen Recent Development
Table 103. Blinatumomab Drugs Distributors List
Table 104. Blinatumomab Drugs Customers List
Table 105. Global Blinatumomab Drugs Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 106. Global Blinatumomab Drugs Sales Forecast by Type 2021-2026 (K Units)
Table 107. Global Blinatumomab Drugs Sales Forecast by Application 2021-2026 (K Units)
Table 108. Global Blinatumomab Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 109. Global Blinatumomab Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 110. North America Blinatumomab Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 111. North America Blinatumomab Drugs Revenue Forecast by Countries 2021-2026
Table 112. Europe Blinatumomab Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 113. Europe Blinatumomab Drugs Revenue Market Share Forecast by Countries 2021-2026
Table 114. Asia Pacific Blinatumomab Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 115. Asia Pacific Blinatumomab Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 116. Latin America Blinatumomab Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 117. Latin America Blinatumomab Drugs Revenue Forecast by Countries 2021-2026 (Million US$)
Table 118. Middle East and Africa Blinatumomab Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 119. Middle East and Africa Blinatumomab Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Blinatumomab Drugs Product Picture
Figure 2. Global Blinatumomab Drugs Sales Market Shar by Type 2015-2026
Figure 3. Prefilled Figures
Figure 4. Non-prefilled Figures
Figure 5. Global Blinatumomab Drugs Sales Market Share by Application in 2019 & 2026
Figure 6. Hospital Use Case
Figure 7. Pharmacy Use Case
Figure 8. Blinatumomab Drugs Report Years Considered
Figure 9. Global Blinatumomab Drugs Market Size 2015-2026 (Million US$)
Figure 10. Global Blinatumomab Drugs Sales 2015-2020 (K Units)
Figure 11. Global Blinatumomab Drugs Market Size Market Share by Regions 2015-2020
Figure 12. Global Blinatumomab Drugs Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Blinatumomab Drugs Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Blinatumomab Drugs Sales in 2019
Figure 16. Blinatumomab Drugs Value Share by Manufacturers in 2019
Figure 17. Blinatumomab Drugs Revenue Share by Manufacturers In 2019
Figure 18. Blinatumomab Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Blinatumomab Drugs Revenue Share by Type (2015-2020)
Figure 20. Global Blinatumomab Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Blinatumomab Drugs Market Share by Price Range (2015-2020)
Figure 22. Global Blinatumomab Drugs Revenue Share by Application (2015-2020)
Figure 23. Global Blinatumomab Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Blinatumomab Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 27. Europe Blinatumomab Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 29. France Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 30. U.K. Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 31. Italy Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 32. Russia Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. Asia Pacific Blinatumomab Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Japan Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. South Korea Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. India Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Australia Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Taiwan Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. Indonesia Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Thailand Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. Malaysia Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Philippines Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Vietnam Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Latin America Blinatumomab Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Brazil Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Argentina Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Middle East and Africa Blinatumomab Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Saudi Arabia Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.A.E Blinatumomab Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Blinatumomab Drugs Value Chain
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. North America Blinatumomab Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 58. North America Blinatumomab Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 59. Europe Blinatumomab Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 60. Europe Blinatumomab Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 61. Asia Pacific Blinatumomab Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 62. Asia Pacific Blinatumomab Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 63. Latin America Blinatumomab Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 64. Latin America Blinatumomab Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 65. Middle East and Africa Blinatumomab Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 66. Middle East and Africa Blinatumomab Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed


【掲載企業】

Amgen

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ブリナツモマブ薬の世界市場2020-2026:事前入力済み、未入力済み(Global Blinatumomab Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。